Cardio Risk Check: what does this mean exactly?

A Cardio Risk Check from MyBody-X typically involves analyzing genetic variants associated with cardiovascular disease. Common targets include SNPs in genes like 9p21, APOE, LPA, or KIF6, which have been linked to modest risk increases in GWAS. However, the evidence is mostly 'GWAS' or 'human-moderate': effect sizes are small, and predictive value for individuals is limited. Traditional risk factors—smoking, hypertension, cholesterol, diabetes, physical activity—are far more impactful. A DNA test alone cannot provide a comprehensive cardiovascular risk assessment. MyBody-X may combine genetic data with biomarkers (e.g., LDL, CRP) and lifestyle inputs, but without specific context, the exact panel is unclear. Caution: 'elevated risk' does not mean disease, and 'low risk' does not guarantee health. Always consult a physician for clinical risk evaluation. Evidence is mixed because some markers (e.g., Lp(a)) have stronger clinical utility than others.